Bio: Larry Gerrans
Larry Gerrans
Co- Founder, President and CEO, Sanovas
Smith & Nephew Corporation
- Delivered over $100 million in new business/contracts in 4 years
- Built & Led National teams focused on emerging technology & markets
- Developed & Managed National Sales & Contracting of Digital OR
- Developed & Managed Hip Arthroscopy System & National Sales
Stryker Corporation
- Endo-Suite™ became $400M Business Unit & $1 Billion+ Industry
- Innovated Minimally Invasive Surgical Technologies & Techniques
- Architected Voice Activated OR & Surgical Device Control System - Hermes™
- Developed First Human Factored, Tele-Medicine OR - Endo-Suite™
- Led Development of Hip Arthroscopy & Saphenous Vein Harvesting System
Depuy Orthopedics (Johnson & Johnson)
- Delivered First National Contract in growing $20M Division
- Distribution & Sales of Orthopedic, Spine & Sports Medicine Implants
- Taught Primary & Revision Total Joint Arthroplasty Techniques
- Led Development Team on Total Shoulder Arthroplasty & Hip Arthroscopy
Larry's career has spanned international trade, surgical devices and information technology. He founded Catapult International, an International Procurement and Export Management Company; an enterprise he later merged with Universal Exports Limited serving as President of Healthcare while building a $25 million division.
Mr. Gerrans then ventured into Orthopedic Implant Sales as a Total Joint Replacement specialist for Depuy Orthopedics (J&J). While working with many of the world's premier orthopedic surgeons in the education and intra-operative consultation of primary and revision total joint arthroplasty he quickly developed a passion for the business. He became a recognized expert in the training and consultation of mobile bearing knee arthroplasty and was a clinical development specialist in the launch of various total joint arthroplasty and spine reconstruction systems; growing his business unit to $25M.
As Minimally Invasive Surgery became prevalent in the 1990's Mr. Gerrans played an active role in the innovation and deployment of MIS techniques, devices and implants for the burgeoning endoscopic market to include surgical devices and protocol for Cardio-Thoracic, General, Urological, Neuro, Gynecological, ENT and Orthopedic /Sports Medicine Surgery.
During this period of advance, Mr. Gerrans became adept at developing and managing highly effective design teams among Surgeons, Engineers and Management. As such, Mr. Gerrans team was among the first medical industry personnel to enter the Los Alamos National Laboratory to evaluate various technologies for transfer to private industry. The most recognizable being the solution to the Oxy-Hydro combustion equation; relating to the use of radiofrequency ablation technology for soft tissue modification in Orthopedic Sports Medicine.
He innovated the Endo-Suite (Stryker) and Digital Operating Room (S&N); developing and deploying the medical industry's first voice-activation technology for surgical device control in the operating theatre - the Hermes Voice Activation and Surgical Device Control System. His technology development and acquisition initiatives grew this new technology sector into a $500 million annual business enterprise.
His personal initiative in Technology, Business Development and National Contracting works on behalf of Smith & Nephew culminated in Smith & Nephew being awarded an $80 million national sole-source contract with Kaiser Permanente Medical Group for the development and construction of over 250 Digital Operating Rooms as well as a $15 million contract award for Sports Medicine devices and implants. Mr. Gerrans has gained extensive organizational development and P&L experience; working for Depuy (J&J), Stryker, Smith & Nephew and Halo Management Group. He has advanced through Sales to positions of Key Market Specialist, Director of Business Development, Director of Sales, Vice President and General Manager.
